The Parenteral Drug Association Expands use of InfoStrength Smart Enterprise Suite
Released on: February 1, 2008, 5:49 am
Press Release Author: Richard Novacek
Industry: Pharmaceuticals
Press Release Summary: PDA uses InfoStrength Smart Enterprise Suite to increase collaboration among its members worldwide.
Press Release Body: PDA uses InfoStrength Smart Enterprise Suite to increase collaboration among its members worldwide.
InfoStrength Smart Enterprise Suite creates collaborative work environments for the Parenteral Drug Association (PDA) worldwide Task Forces that support the development of Technical Bulletins and Reports. These PDA products offer expert guidance, best practices, and opinions on a variety of important scientific and regulatory topics pertaining to pharmaceutical and biopharmaceutical production.
"InfoStrength enables more effective collaboration among the members of our many Task Forces which in turn enables PDA to better serve the needs of our members and the life science industry," said Rich Levy, Senior Vice President Scientific and Regulatory Affairs at PDA.
About PDA
Connecting People, Science and Regulation® The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.
About InfoStrength InfoStrength®, Inc., exclusively serving biotechnology, pharmaceutical and medical device companies with internationally recognized regulatory expertise, developed InfoStrength® Smart Enterprise Suite (SES) with an innovative software development methodology specifically created for FDA regulated environments. InfoStrength SES is a configurable, modular, web-based application solution specifically designed to address business and regulatory initiatives of life science companies. InfoStrength® SES enables sharing critical information while ensuring management control, milestone accountability and market differentiating collaboration. The InfoStrength® solution delivers document, project and process management along with regulatory compliance controls and a robust validation package. Additional information about InfoStrength can be obtained from the company\'s website on the Internet at www.infostrength.com
Web Site: http://www.infostrength.com/about/news/release.aspx?n=60
Contact Details: InfoStrength Inc. 4220 Apex Highway Duite 200